VTYX250117P7500
- 5.01
- 0.000.00%
Ventyx Biosciences Newsroom
Ventyx Biosciences Insiders Land Bargain With Gains Of US$180k
Founder of Ventyx Biosciences Picks Up 30% More Stock
Morgan Stanley Maintains Ventyx Biosciences(VTYX.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Ventyx Biosciences (VTYX)
Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 43% Over the Past Week
Neurogene and Ventyx Biosciences Rises After Insider Buying by Executives
Insider Purchase: CEO AND PRESIDENT of $VTYX (VTYX) Buys 238,248 Shares
Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) Latest 15% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
Ventyx Biosciences Reports Q3 Financial Results and Pipeline Progress
Ventyx Biosciences Analyst Ratings
Oppenheimer Maintains Ventyx Biosciences(VTYX.US) With Buy Rating, Cuts Target Price to $9
Ventyx Biosciences (VTYX) Receives a Buy From LifeSci Capital
Express News | Ventyx Biosciences : Oppenheimer Cuts Target Price to $9 From $10
Ventyx Biosciences Reports Q3 EPS (52c), Consensus ( 53c)
Ventyx Biosciences Files to Sell 7.06M Shares of Common Stock for Holders
Express News | Ventyx Biosciences Inc: Cash Balance of $274.8M as of September 30, 2024 Expected to Fund Operations Into at Least H2 2026
Ventyx Biosciences | 10-Q: Q3 2024 Earnings Report
Earnings Flash (VTYX) VENTYX BIOSCIENCES Reports Q3 Loss $-0.50
Express News | Ventyx Biosciences Q3 Net Income USD -35.249 Million